Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is a Healthcare company (Biotechnology) with a market capitalization of $9.2B. The Maz Rating grades it against the other companies in its sector.
Praxis Precision Medicines, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $328.13, Praxis Precision Medicines, Inc. trades at 7.6x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -29.4%, return on invested capital of -32.3% and a free cash flow yield of -3.5%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 14.53. Over the past 52 weeks the share price ranged from $160.11 to $392.70, with a beta of 2.84.
Praxis Precision Medicines, Inc. does not currently pay a dividend.
18 Wall Street analyst ratings cover the stock: 14 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.